Effects of NMDA antagonists on ethanol-withdrawal induced 'anxiety' in the elevated plus maze

Alcohol

Volumn 19, Issue 3, 1999, Pages 207-211

  Gatch, Michael B ^a   Wallis, Cleatus J ^a   Lal, Harbans ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Anxiety; AP 7; CGP 37849; Dizocilpine; Ethanol withdrawal; HA 966; N methyl D aspartate receptor; Rats

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 2 AMINO 7 PHOSPHONOHEPTANOIC ACID; 3 AMINO 1 HYDROXY 2 PYRROLIDINONE; ALCOHOL; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; NONHUMAN; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; MALE; MAZE LEARNING; RATS; RATS, LONG-EVANS; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032692770     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-8329(99)00045-2     Document Type: Article

References (29)

1. Alexander, S.; Peters, J.: Receptor and ion channel nomenclature supplement. Cambridge: Elsevier Science, Ltd.; 1999.
2. Bischoff C., Tiedtke P.I. Competitive and non-competitive NMDA receptor antagonists in spatial learning tasks. Eur. J. Pharmacol. 213:1992;269-273.
3. Carter L.A., Belknap J.K., Crabbe J.C., Janowsky A. Allosteric regulation of the N-methyl-D-aspartate receptor-linked ion channel complex and effects of ethanol in ethanol-withdrawal seizure-prone and -resistant mice. J. Neurochem. 64:1995;213-219.
4. De Souza M.M., Schenberg L.C., de Padua Carobrez A. NMDA-coupled periaqueductal gray glycine receptors modulate anxioselective drug effects on plus-maze performance. Behav. Brain Res. 90:1998;157-165.
5. Dunn R.W., Flanagan D.M., Martin L.L., Kerman L.L., Woods A.T., Camacho F., Wilmot C.A., Cornfeldt M.L., Effland R.C., Wood P.L., Al E. Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents. Eur. J. Pharmacol. 214:1992;207-214.
6. Goldstein D.B. Relationship of alcohol dose to intensity of withdrawal signs in mice. J. Pharmacol. Exp. Ther. 180:1972;203-215.
7. Grant K., Snell L., Rogawski M., Thurkauf A., Tabakoff B. Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H-diben-zo[a,d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. J. Pharmacol. Exp. Ther. 260:1992;1017-1022.
8. Grant K.A., Valverius P., Hudspith M., Tabakoff B. Ethanol withdrawal seizures and the NMDA receptor complex. Eur. J. Pharmacol. 176:1990;289-296.
9. Hoffman P., Rabe C., Moses F., Tabakoff B. N-Methyl-D-aspartate receptors and ethanol. inhibition of calcium flux and cyclic GMP production J. Neurochem. 52:1989;1937-1940.
10. Hoffman P.L. Glutamate receptors in alcohol withdrawal-induced neurotoxicity. Metab. Brain. Dis. 10:1995;73-79.
11. Hoffman P.L., Iorio K.R., Snell L.D., Tabakoff B. Attenuation of glutamate-induced neurotoxicity in chronically ethanol-exposed cerebellar granule cells by NMDA receptor antagonists and ganglioside GM1. Alcohol Clin. Exp. Res. 19:1995;721-726.
12. Jessa M., Nazar M., Bidzinski A., Plaznik A. The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety. Eur. Neuropsychopharmacol. 6:1996;55-61.
13. Jessa M., Nazar M., Pláznik A. Anxiolytic-like action of intra-hippocampally administered NMDA antagonists in rats. Pol. J. Pharmacol. 47:1995;81-84.
14. Kotlinska J., Liljequist S. Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures. Psychopharmacol. 127:1996;238-244.
15. Kotlinska J., Liljequist S. A characterization of anxiolytic-like actions induced by the novel NMDA/glycine site antagonist, L-701,324. Psychopharmacol. 135:1998;175-181.
16. Löscher W., Nolting B., Hönack D. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital. Eur. J. Pharmacol. 152:1988;9-17.
17. Lovinger D., White G., Weight F. Ethanol inhibits NMDA-activiated ion current in hippocampal neurons. Science. 243:1989;1721.
18. Matheus M.G., Guimaraes F.S. Antagonism of non-NMDA receptors in the dorsal periaqueductal grey induces anxiolytic effect in the elevated plus maze. Psychopharmacology. 132:1997;14-18.
19. Matheus M.G., Nogueira R.L., Carobrez A.P., Graeff F.G., Guimares F.S. Anxiolytic effect of glycine antagonists microinjected into the dorsal periaqueductal grey. Psychopharmacol. 113:1994;565-569.
20. Matsumoto I., Davidson M., Otsuki M., Wilce P.A., Morgan P.F., Nadi N.S., Karanian J., Linnoila M. Decreased severity of ethanol withdrawal behaviors in kainic acid-treated rats. Pharmacol. Biochem. Behav. 55:1996;371-378.
21. Michaelis E.K., Mulvaney M.J., Freed W.J. Effects of acute and chronic ethanol intake on synaptosomal glutamate binding activity. Biochem. Pharmacol. 27:1978;1685-1691.
22. Moraes Ferreira V.M., Morato G.S. D-cycloserine blocks the effects of ethanol and HA-966 in rats tested in the elevated plus-maze. Alcohol. Clin. Exp. Res. 21:1997;1638-1642.
23. Rabe C.S., Tabakoff B. Glycine site-directed agonists reverse the actions of ethanol at the N-methyl-D-aspartate receptor. Mol. Pharmacol. 38:1990;753-757.
24. Ripley T.L., Little H.J. Ethanol withdrawal hyperexcitability in vitro is selectively decreased by a competitive NMDA receptor antagonist. Brain Res. 699:1995;1-11.
25. Singh L., Menzies R., Tricklebank M. The discriminative stimulus properties of (+)-HA-966, an antagonist at the glycine/N-methyl-D-aspartate receptor. Eur. J. Pharmacol. 186:1990;129-132.
26. Snell L.D., Tabakoff B., Hoffman P.L. Radioligand binding to the N-methyl-D-aspartate receptor/ionophore complex. alterations by ethanol in vitro and by chronic in vivo ethanol ingestion Brain Res. 602:1993;91-98.
27. Valverius P., Crabbe J.C., Hoffman P.L., Tabakoff B. NMDA receptors in mice bred to be prone or resistant to ethanol withdrawal seizures. Eur. J. Pharmacol. 184:1990;185-189.
28. Wallis C.J., Rezazadeh S.M., Lal H. GM1 ganglioside reduces ethanol intoxication and the development of ethanol dependence. Alcohol. 12:1995;573-580.
29. Wiley J.L., Cristello A.F., Balster R.L. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice. Eur. J. Pharmacol. 294:1995;101-107.